Sinocare Inc
SZSE:300298

Watchlist Manager
Sinocare Inc Logo
Sinocare Inc
SZSE:300298
Watchlist
Price: 23.29 CNY -5.56% Market Closed
Market Cap: 12.9B CNY
Have any thoughts about
Sinocare Inc?
Write Note

Sinocare Inc
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sinocare Inc
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Sinocare Inc
SZSE:300298
Accounts Receivables
ÂĄ614.1m
CAGR 3-Years
23%
CAGR 5-Years
13%
CAGR 10-Years
24%
A
APT Medical Inc
SSE:688617
Accounts Receivables
ÂĄ41.4m
CAGR 3-Years
-2%
CAGR 5-Years
10%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Accounts Receivables
ÂĄ1.1B
CAGR 3-Years
13%
CAGR 5-Years
-6%
CAGR 10-Years
6%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Accounts Receivables
ÂĄ4B
CAGR 3-Years
28%
CAGR 5-Years
17%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Accounts Receivables
ÂĄ72m
CAGR 3-Years
-36%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Accounts Receivables
ÂĄ3.3B
CAGR 3-Years
67%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sinocare Inc
Glance View

Market Cap
13.1B CNY
Industry
Health Care

Sinocare, Inc. engages in the research, development, manufacture, and commercialization of biosensor-based blood glucose monitoring systems. The company is headquartered in Changsha, Hunan and currently employs 3,534 full-time employees. The company went IPO on 2012-03-19. The firm mainly provides micro blood instant blood sugar monitoring systems including blood sugar testing instruments and related blood sugar testing strips, as well as blood sugar testing systems and mobile blood sugar instruments, among others. The firm also provides diabetes management information systems. The company distributes its products within domestic market and to overseas markets under the brand name of SANNUO.

Intrinsic Value
36.62 CNY
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Sinocare Inc's Accounts Receivables?
Accounts Receivables
614.1m CNY

Based on the financial report for Jun 30, 2024, Sinocare Inc's Accounts Receivables amounts to 614.1m CNY.

What is Sinocare Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
24%

Over the last year, the Accounts Receivables growth was 12%. The average annual Accounts Receivables growth rates for Sinocare Inc have been 23% over the past three years , 13% over the past five years , and 24% over the past ten years .

Back to Top